Tendinopathies represent a serious challenge for orthopaedic surgeons involved in treatment of athletes.
Purpose:
To compare the effectiveness and safety of platelet-rich plasma (PRP) injections and focused extracorporeal shock wave therapy (ESWT) in athletes with jumper’s knee.
Study Design:
Randomized controlled trial; Level of evidence, 1.
Methods:
Forty-six consecutive athletes with jumper’s knee were selected for this study and randomized into 2 treatment groups: 2 autologous PRP injections over 2 weeks under ultrasound guidance (PRP group; n = 23), and 3 sessions of focused extracorporeal shock wave therapy (2.400 impulses at 0.17-0.25 mJ/mm2 per session) (ESWT group; n = 23). The outcome measures were Victorian Institute of Sports Assessment–Patella (VISA-P) questionnaire, pain visual analog scale (VAS), and modified Blazina scale. A reviewer who was blinded as to the group allocation of participants performed outcome assessments before treatment and at 2, 6, and 12 months after treatment. Nonparametric tests were used for within-group (Friedman/Wilcoxon test) and between-group (Kruskal-Wallis/Fisher test) testing, and the significance level was set at .05.
Results:
The 2 groups were homogeneous in terms of age, sex, level of sports participation, and pretreatment clinical status. Patients in both groups showed statistically significant improvement of symptoms at all follow-up assessments. The VISA-P, VAS, and modified Blazina scale scores showed no significant differences between groups at 2-month follow-up (P = .635, .360, and .339, respectively). The PRP group showed significantly better improvement than the ESWT group in VISA-P, VAS scores at 6- and 12-month follow-up, and modified Blazina scale score at 12-month follow-up (P < .05 for all).
Conclusion:
Therapeutic injections of PRP lead to better midterm clinical results compared with focused ESWT in the treatment of jumper’s knee in athletes.
AnituaEAndiaISanchezM. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005;23(2):281-286.
2.
CarofinoBChowaniecDMMcCarthyMB. Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: an in vitro study on human tendon cells. Arthroscopy. 2012;28(5):711-719.
3.
CookJLKhanKMKissZSPurdamCRGriffithsL. Prospective imaging study of asymptomatic patellar tendinopathy in elite junior basketball players. J Ultrasound Med. 2000;19(7):473-479.
4.
CotchettMPLandorfKBMunteanuSERaspovicAM. Consensus for dry needling for plantar heel pain (plantar fasciitis): a modified Delphi study. Acupunct Med. 2011;29(3):193-202.
5.
CreaneyLWallaceACurtisMConnellD. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, double-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45(12):966-971.
6.
de VosRJWeirAvan SchieHT. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-149.
7.
DimitriosSPantelisMKalliopiS. Comparing the effects of eccentric training with eccentric training and static stretching exercises in the treatment of patellar tendinopathy: a controlled clinical trial. Clin Rehabil. 2012;26(5):423-430.
8.
EdwardsSGCalandruccioJH. Autologous blood injections for refractory lateral epicondylitis. J Hand Surg Am. 2003;28(2):272-278.
9.
FerrettiAConteducaFCamerucciEMorelliF. Patellar tendinosis: a follow-up study of surgical treatment. J Bone Joint Surg Am. 2002;84(12):2179-2185.
10.
FerrettiAIppolitoEMarianiPPudduG. Jumper’s knee. Am J Sports Med. 1983;11(2):58-62.
11.
FerrettiAPudduGMarianiPPNeriM. Jumper’s knee: an epidemiological study of volleyball players. Physician Sportsmed. 1984;12(10):97-106.
12.
FerrettiAPudduGMarianiPPNeriM. The natural history of jumper’s knee: patellar or quadrictif tendonitis. Int Orthop. 1985;8(4):239-242.
13.
FilardoGKonEDella VillaSVincentelliFFornasariPMMarcacciM. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34(6):909-915.
14.
FrairiaRBertaL. Biological effects of extracorporeal shock waves on fibroblasts: a review. Muscles, Ligaments and Tendons Journal. 2011;1(4):137-146.
15.
GosensTDen OudstenBLFievezEvan’t SpijkerPFievezA. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36(9):1941-1946.
16.
Hernandez-SanchezSHidalgoMDGomezA. Cross-cultural adaptation of VISA-P score for patellar tendinopathy in Spanish population. J Orthop Sports Phys Ther. 2011;41(8):581-591.
17.
HoksrudABahrR. Ultrasound-guided sclerosing treatment in patients with patellar tendinopathy (jumper’s knee): 44-month follow-up. Am J Sports Med. 2011;39(11):2377-2380.
18.
JamesSLAliKPocockC. Ultrasound guided dry needling and autologous blood injection for patellar tendinosis. Br J Sports Med. 2007;41(8):518-521; discussion 522.
19.
KawasumiMKitohHSiwickaKAIshiguroN. The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br. 2008;90(7):966-972.
20.
KazemiMAzmaKTavanaBRezaiee MoghaddamFPanahiA. Autologous blood versus corticosteroid local injection in the short-term treatment of lateral elbow tendinopathy: a randomized clinical trial of efficacy. Am J Phys Med Rehabil. 2010;89(8):660-667.
21.
KimESParkEJChoungPH. Platelet concentration and its effect on bone formation in calvarial defects: an experimental study in rabbits. J Prosthet Dent. 2001;86(4):428-433.
22.
KlonschinskiTAmentSJSchlerethTRompeJDBirkleinF. Application of local anesthesia inhibits effects of low-energy extracorporeal shock wave treatment (ESWT) on nociceptors. Pain Med. 2011;12(10):1532-1537.
23.
KongsgaardMKovanenVAagaardP. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009;19(6):790-802.
24.
KremerEAtkinsonJHIgnelziRJ. Measurement of pain: patient preference does not confound pain measurement. Pain. 1981;10(2):241-248.
25.
LeoneLVetranoMRanieriD. Extracorporeal shock wave treatment (ESWT) improves in vitro functional activities of ruptured human tendon-derived tenocytes. PLoS One. 2012;7(11):e49759.
26.
LianOBEngebretsenLBahrR. Prevalence of jumper’s knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med. 2005;33(4):561-567.
27.
Lopez-VidrieroEGouldingKASimonDASanchezMJohnsonDH. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy. 2010;26(2):269-278.
28.
LyrasDKazakosKVerettasD. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop. 2010;34(1):143-148.
29.
MaffulliNLongoUGDenaroV. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010;92(15):2604-2613.
30.
MaffulliNLongoUGLoppiniMDenaroV. Current treatment options for tendinopathy. Expert Opin Pharmacother. 2010;11(13):2177-2186.
31.
MaffulliNLongoUGTestaVOlivaFCapassoGDenaroV. VISA-P score for patellar tendinopathy in males: adaptation to Italian. Disabil Rehabil. 2008;30(20-22):1621-1624.
32.
MarxRE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489-496.
33.
MolloyTWangYMurrellG. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381-394.
34.
NotarnicolaAMorettIB. The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles, Ligaments and Tendons Journal. 2012;2(1):33-37.
35.
PearsonJRowlandsDHighetR. Autologous blood injection for treatment of Achilles tendinopathy? A randomised controlled trial. J Sport Rehabil. 2012;21(3):218-224.
36.
PeerboomsJCSluimerJBruijnDJGosensT. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255-262.
37.
Romero-RodriguezDGualGTeschPA. Efficacy of an inertial resistance training paradigm in the treatment of patellar tendinopathy in athletes: a case-series study. Phys Ther Sport. 2011;12(1):43-48.
38.
RompeJDMeurerANafeBHofmannAGerdesmeyerL. Repetitive low-energy shock wave application without local anesthesia is more efficient than repetitive low-energy shock wave application with local anesthesia in the treatment of chronic plantar fasciitis. J Orthop Res. 2005;23(4):931-941.
TaylorDWPetreraMHendryMTheodoropoulosJS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011;21(4):344-352.
41.
ThanasasCPapadimitriouGCharalambidisCParaskevopoulosIPapanikolaouA. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011;39(10):2130-2134.
42.
van LeeuwenMTZwerverJvan den Akker-ScheekI. Extracorporeal shockwave therapy for patellar tendinopathy: a review of the literature. Br J Sports Med. 2009;43(3):163-168.
43.
VetranoMd’AlessandroFTorrisiMRFerrettiAVulpianiMCViscoV. Extracorporeal shock wave therapy promotes cell proliferation and collagen synthesis of primary cultured human tenocytes. Knee Surg Sports Traumatol Arthrosc. 2011;19(12):2159-2168.
44.
VolpiPMarinoniLBaitCDe GirolamoLSchoenhuberH. Treatment of chronic patellar tendinosis with buffered platelet rich plasma: a preliminary study. Med Sport. 2007;60(4):595-603.
45.
VulpianiMCVetranoMSavoiaVDi PangrazioETrischittaDFerrettiA. Jumper’s knee treatment with extracorporeal shock wave therapy: a long-term follow-up observational study. J Sports Med Phys Fitness. 2007;47(3):323-328.
46.
WangCJHuangHYPaiCH. Shock wave-enhanced neovascularization at the tendon-bone junction: an experiment in dogs. J Foot Ankle Surg. 2002;41(1):16-22.
47.
ZwerverJHartgensFVerhagenEvan der WorpHvan den Akker-ScheekIDiercksRL. No effect of extracorporeal shockwave therapy on patellar tendinopathy in jumping athletes during the competitive season: a randomized clinical trial. Am J Sports Med. 2011;39(6):1191-1199.
